Dendreon files Chapter 11 (DNDN) - Seeking Alpha (registration)

11/10/14

Dendreon files Chapter 11 (DNDN)
Seeking Alpha (registration)
When the prostate cancer therapy was approved in 2010, analysts forecasted peak sales of over $4B. Last year's top line was ~$284M. DNDN is off 65% premarket on light volume but the turnover will increase dramatically as the open approaches. Shares ...

[more]